[PHARMA] YoY Annual (Unaudited) Result on 31-Dec-2004 [#4]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
23-Feb-2005
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2004
Quarter
31-Dec-2004 [#4]
Profit Trend
YoY- 24.73%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Annual (Unaudited) Result
31/12/07 31/12/06 31/12/05 31/12/04 31/12/03 31/12/02 31/12/01 CAGR
Revenue 1,183,983 1,057,868 936,431 799,991 632,604 585,237 543,496 13.84%
PBT 77,898 27,195 42,072 81,778 66,841 61,170 51,604 7.10%
Tax -26,180 -13,111 -12,938 -30,943 -26,085 -23,829 -20,800 3.90%
NP 51,718 14,084 29,134 50,835 40,756 37,341 30,804 9.01%
-
NP to SH 50,080 12,481 26,902 50,835 40,756 37,341 30,804 8.43%
-
Tax Rate 33.61% 48.21% 30.75% 37.84% 39.03% 38.96% 40.31% -
Total Cost 1,132,265 1,043,784 907,297 749,156 591,848 547,896 512,692 14.10%
-
Net Worth 349,768 316,570 304,433 263,393 222,305 180,197 160,520 13.85%
Dividend
31/12/07 31/12/06 31/12/05 31/12/04 31/12/03 31/12/02 31/12/01 CAGR
Div 19,253 12,299 14,496 15,195 12,016 8,509 3,750 31.32%
Div Payout % 38.45% 98.54% 53.89% 29.89% 29.48% 22.79% 12.18% -
Equity
31/12/07 31/12/06 31/12/05 31/12/04 31/12/03 31/12/02 31/12/01 CAGR
Net Worth 349,768 316,570 304,433 263,393 222,305 180,197 160,520 13.85%
NOSH 106,962 106,949 103,548 101,305 100,137 100,109 50,006 13.50%
Ratio Analysis
31/12/07 31/12/06 31/12/05 31/12/04 31/12/03 31/12/02 31/12/01 CAGR
NP Margin 4.37% 1.33% 3.11% 6.35% 6.44% 6.38% 5.67% -
ROE 14.32% 3.94% 8.84% 19.30% 18.33% 20.72% 19.19% -
Per Share
31/12/07 31/12/06 31/12/05 31/12/04 31/12/03 31/12/02 31/12/01 CAGR
RPS 1,106.91 989.13 904.34 789.68 631.73 584.59 1,086.85 0.30%
EPS 46.82 11.67 25.98 50.18 40.70 37.30 61.60 -4.46%
DPS 18.00 11.50 14.00 15.00 12.00 8.50 7.50 15.70%
NAPS 3.27 2.96 2.94 2.60 2.22 1.80 3.21 0.30%
Adjusted Per Share Value based on latest NOSH - 101,890
31/12/07 31/12/06 31/12/05 31/12/04 31/12/03 31/12/02 31/12/01 CAGR
RPS 82.15 73.40 64.97 55.51 43.89 40.61 37.71 13.84%
EPS 3.47 0.87 1.87 3.53 2.83 2.59 2.14 8.38%
DPS 1.34 0.85 1.01 1.05 0.83 0.59 0.26 31.41%
NAPS 0.2427 0.2196 0.2112 0.1828 0.1542 0.125 0.1114 13.85%
Price Multiplier on Financial Quarter End Date
31/12/07 31/12/06 31/12/05 31/12/04 31/12/03 31/12/02 31/12/01 CAGR
Date 31/12/07 29/12/06 30/12/05 31/12/04 31/12/03 31/12/02 31/12/01 -
Price 2.93 3.73 4.64 5.27 4.82 3.80 7.27 -
P/RPS 0.26 0.38 0.51 0.67 0.76 0.65 0.67 -14.58%
P/EPS 6.26 31.96 17.86 10.50 11.84 10.19 11.80 -10.02%
EY 15.98 3.13 5.60 9.52 8.44 9.82 8.47 11.15%
DY 6.14 3.08 3.02 2.85 2.49 2.24 1.03 34.63%
P/NAPS 0.90 1.26 1.58 2.03 2.17 2.11 2.26 -14.21%
Price Multiplier on Announcement Date
31/12/07 31/12/06 31/12/05 31/12/04 31/12/03 31/12/02 31/12/01 CAGR
Date 28/02/08 26/02/07 07/03/06 23/02/05 19/02/04 10/04/03 20/02/02 -
Price 2.98 3.65 4.73 4.95 5.23 3.62 6.77 -
P/RPS 0.27 0.37 0.52 0.63 0.83 0.62 0.62 -12.93%
P/EPS 6.36 31.28 18.21 9.86 12.85 9.71 10.99 -8.70%
EY 15.71 3.20 5.49 10.14 7.78 10.30 9.10 9.52%
DY 6.04 3.15 2.96 3.03 2.29 2.35 1.11 32.60%
P/NAPS 0.91 1.23 1.61 1.90 2.36 2.01 2.11 -13.07%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment